Rhabdomyolysis after correction of hyponatremia due to psychogenic polydipsiaRIZZIERI, D. A.Mayo Clinic proceedings. 1995, Vol 70, Num 5, pp 473-476, issn 0025-6196Article

Leukemic Stem Cells: A ReviewO'BRIEN, J. A; RIZZIERI, D. A.Cancer investigation. 2013, Vol 31, Num 1-10, pp 215-220, issn 0735-7907, 6 p.Article

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantationKANDA, J; HORWITZ, M. E; RIZZIERI, D. A et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 5, pp 700-705, issn 0268-3369, 6 p.Article

Genetic analysis of dicofol resistance in two populations of twospotted spider mite (Acari: Tetranychidae) from New York apple orchardsRIZZIERI, D. A; DENNEHY, T. J; GLOVER, T. J et al.Journal of economic entomology. 1988, Vol 81, Num 5, pp 1271-1276, issn 0022-0493Article

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemiaWEINBERG, J. B; VOLKHEIMER, A. D; RIZZIERI, D. A et al.Leukemia. 2008, Vol 22, Num 12, pp 2184-2192, issn 0887-6924, 9 p.Article

Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemiaLAUGHLIN, M. J; RIZZIERI, D. A; BUCKLEY, R et al.Leukemia research. 1998, Vol 22, Num 3, pp 215-219, issn 0145-2126Article

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatmentKANDA, J; KAYNAR, L; GASPARETTO, C et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 7, pp 926-931, issn 0268-3369, 6 p.Article

Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donorsCHEN, D.-F; PRASAD, V. K; LONG, G. D et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 6, pp 817-823, issn 0268-3369, 7 p.Article

Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitorRIZZIERI, D. A; LIU, J; TRAWEEK, S. T et al.Lancet (British edition). 1997, Vol 349, Num 9054, pp 775-776, issn 0140-6736Article

Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejectionBYRNE, B. J; HORWITZ, M; LONG, G. D et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 1, pp 39-43, issn 0268-3369, 5 p.Article

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administrationHORWITZ, M. E; CHUTE, J. P; GASPARETTO, C et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 8, pp 1051-1055, issn 0268-3369, 5 p.Article

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisKHOURY, H. J; KUKREJA, M; GALE, R. P et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 6, pp 810-816, issn 0268-3369, 7 p.Article

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cellsJORDAN, C. T; UPCHURCH, D; LUGER, S. M et al.Leukemia. 2000, Vol 14, Num 10, pp 1777-1784, issn 0887-6924Article

Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell supportRIZZIERI, D. A; VREDENBURGH, J. J; AFFRONTI, M. L et al.Journal of clinical oncology. 1999, Vol 17, Num 10, pp 3064-3074, issn 0732-183XArticle